175 related articles for article (PubMed ID: 23761054)
21. Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules.
Sabri A; Ogilvie J; McKenna J; Segal J; Scurr D; Marlow M
Mol Pharm; 2020 Aug; 17(8):2925-2937. PubMed ID: 32510228
[TBL] [Abstract][Full Text] [Related]
22. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.
Baek C; Han M; Min J; Prausnitz MR; Park JH; Park JH
J Control Release; 2011 Sep; 154(2):138-47. PubMed ID: 21586307
[TBL] [Abstract][Full Text] [Related]
23. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
Duarah S; Sharma M; Wen J
Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional printing of a microneedle array on personalized curved surfaces for dual-pronged treatment of trigger finger.
Lim SH; Ng JY; Kang L
Biofabrication; 2017 Jan; 9(1):015010. PubMed ID: 28071597
[TBL] [Abstract][Full Text] [Related]
26. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
27. Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population.
Kelchen MN; Holdren GO; Farley MJ; Zimmerman MB; Fairley JA; Brogden NK
Pharm Res; 2014 Dec; 31(12):3478-86. PubMed ID: 24947437
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo evaluation of a microneedle array device for transdermal application.
Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
[TBL] [Abstract][Full Text] [Related]
29. Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
Banks SL; Pinninti RR; Gill HS; Crooks PA; Prausnitz MR; Stinchcomb AL
Pharm Res; 2008 Jul; 25(7):1677-85. PubMed ID: 18449628
[TBL] [Abstract][Full Text] [Related]
30. Review of patents for microneedle application devices allowing fluid injections through the skin.
Lhernould MS; Tailler S; Deleers M; Delchambre A
Recent Pat Drug Deliv Formul; 2015; 9(2):146-57. PubMed ID: 25770583
[TBL] [Abstract][Full Text] [Related]
31. Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency.
Tobin KV; Brogden NK
Biomater Sci; 2023 Aug; 11(17):5846-5858. PubMed ID: 37455601
[TBL] [Abstract][Full Text] [Related]
32. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
33. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
[TBL] [Abstract][Full Text] [Related]
34. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
[TBL] [Abstract][Full Text] [Related]
35. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
[TBL] [Abstract][Full Text] [Related]
36. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
37. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
[TBL] [Abstract][Full Text] [Related]
38. Macromolecular delivery into skin using a hollow microneedle.
Wonglertnirant N; Todo H; Opanasopit P; Ngawhirunpat T; Sugibayashi K
Biol Pharm Bull; 2010; 33(12):1988-93. PubMed ID: 21139238
[TBL] [Abstract][Full Text] [Related]
39. Microvascular effects of microneedle application.
Hackethal J; Iredahl F; Henricson J; Anderson CD; Tesselaar E
Skin Res Technol; 2021 Mar; 27(2):121-125. PubMed ID: 32662126
[TBL] [Abstract][Full Text] [Related]
40. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
